Navigation auf uzh.ch
Navigation auf uzh.ch
In a collaborative project funded by Innosuisse and Enzian Pharmaceutics, scientists at Enzian Pharmaceutics and the University of Zurich (UZH) have reached an important milestone in the development of a new gastroretentive dosage form.
As part of the UZH Entrepreneur Fellowships and the UZH Innovation Grants programs, the UZH Innovation Office has launched a brand new event series "Innovator Mornings".
UZH Spin-off Synthara, a chip design startup founded by Manu V Nair and Alessandro Aimar, has been awarded the 2023 ZKB Technopark Pionierpreis. The Zurich-based company is recognised for its innovative approach to chip design, which enhances computing power and energy efficiency.
Venture Kick awarded CHF 150’000 to metaLead, a BioTech UZH Spinoff project, which is developing next-gen antidotes against toxic metals.
CSS and EPFL Innovation Park announced last week the innovation projects that have been selected in their Future of Health (FoHG) program.
The Novartis Institutes for BioMedical Research (NIBR) is seeking to advance science through the NIBR Global Scholars Program (NGSP). This competitive program supports projects focused on novel science with the objective of being translated to drug discovery and/or clinical research. Magdalini Polymenidou has been selected for the NGSP 2022 and will receive up to 1 mil USD funding over three years along with scientific expertise from NIBR collaborators.
Prometheus AG wins the Orbital Reef Starter Innovation Challenge.
Two new UZH spin-offs join ESA BIC Switzerland, the Swiss Space Incubator!
Research collaboration between EraCal Therapeutics and Nestlé Health Science
SignMax is the winner of the Digital Entrepreneurship Bootcamp 2022 edition.
Former UZH MedTech Entrepreneur fellow David Gage and aiEndoscopic won the Swiss Innovation Challenge 2022.
PayMate is the winner team of the UZH Innovathon: Building a human-centered Future of Work.
UZH Entrepreneur Fellow Merens Derungs and his startup Arcton were among the illustrious circle of 6 startups that were allowed to present themselves at the Startup Nights in Winterthur.
The UZH spin-off Navignostics raises CHF 7.5M in a seed financing round to advance precision cancer medicine through spatial single-cell proteomics.
Former MedTech UZH Entrepreneur fellow Dr. Deana Mohr and her company Muvon Therapeutics announce first patient enrolled in phase II clinical study.
Im UZH Innovation Office übernimmst Du administrative und operative Aufgaben zur Unterstützung der verschiedener Aktivitäten im UZH Innovation Hub. Es wartet eine vielseitige und verantwortungsvolle Einstiegsposition in einem dynamischen Umfeld auf Dich.
Former MedTech UZH Entrepreneur fellow Dr. Prajwal and his company Clemedi release Tuberculini, a molecular test for drug-resistant tuberculosis.
Molecular biologist and former UZH Entrepreneur Fellow Ana Montalban-Arques has made a discovery that could cure colon cancer.
InCephalo AG receives EIT Health Gold Track grant
"Engineer the future as an entrepreneur? Why not?" - that was the theme of this year's Credit Suisse Entrepreneurs' Conference. The inspiring panel discussions and keynote speeches also featured entrepreneurial researchers from the University of Zurich.
The UZH Innovation Hub is partnering with Talent Kick, a program where students have the opportunity to form interdisciplinary cross-university co-founder teams and benefit from hands-on entrepreneurial experience during studies.
The University of Zurich with Dr. Sarah Ebling in the lead, has been granted funding for a large innovation project to break communication barriers for better social inclusion. The Swiss Innovation Agency (Innosuisse) has granted CHF 12.4 Mio for this four-year flagship project entitled “Inclusive Information and Communication Technologies” (IICT).
The active ingredient aducanumab, which was discovered at the University of Zurich, has been approved for use in the United States as a treatment for Alzheimer’s disease. Aducanumab, a human antibody, is the first treatment to slow down incurable Alzheimer's disease.
In a facilitated five day innovation sprint students and researchers from three universities will work together to develop, prototype and test new ideas with a focus on sustainability and impact based on the SDGs.
Molecular Partners announced their collaboration with Novartis on potential medicines for use against COVID-19. Molecular Partners will be responsible for Phase 1 and 2 trials for its two therapeutic candidates. If the trials are successful, Novartis will be responsible for further development, manufacturing, and global commercialization.
The majority of the spin-offs founded at the UZH are active in the fields of biotech and medicine. At the UZH Innovation Hub we support research projects in four innovation areas, including biotech and life sciences.
Do you have a voluntary, social enterprise or environmental project that you would like to scale up, develop, and build? Are you looking for additional support and resources to grow your reach? Then U21 RISE is for you.
Kick off your digital business idea with the help of experienced tech founders and experts. Apply now for the Digital Entrepreneurship: Bootcamp!
Find and meet the perfect match thanks to the Futurepreneuship’s “Young professional program” !
Find and meet the perfect match thanks to the Futurepreneuship’s “Young professional program” !
EraCal Therapeutics, a spin-off from the University of Zurich and Harvard University, developed a new drug candidate for obesity and is now a finalist for The Spinoff Prize.
Dave Gage and his team won the final pitch in the Innosuisse Business Concept Course. With aiEndoscopic they are developing an intubation aid for emergency physicians and anesthetists.
Researchers at the University of Zurich have developed a new X-ray contrast agent. The contrast agent is easier to use and distributes into all blood vessels more reliably, increasing the precision of vascular imaging. This reduces the number of animals required in research experiments.
Two UZH startups have been selected for this year’s Venture Leaders Life Sciences program.
Translating findings from medical research into applications to help people — that is the overriding aim of the MedTechEntrepreneur Fellowships at the University of Zurich, which are funded by the Werner Siemens Foundation.
Looking for an inspiring internship this summer in the startup & innovation world which brings you further? Apply until April 24 to become a Future.preneur and get ready for the Future of Work.
An imaging approach developed at UZH enables the study of breast cancer tissue in greater detail.
Wingman Ventures is ready to make a mark. The independent venture fund is all about providing know-how and financial support to help Swiss startups become international market leaders. The fund is investing USD 60m in Swiss tech startups exclusively.
According to a new study from researchers at the University of Zurich, dental epithelial stem cells from mice can generate mammary ducts and even milk-producing cells when transplanted into mammary glands.
Swiss researchers co-headed by the University of Zurich have now discovered a new class of antibiotics with a unique spectrum of activity and mechanism of action.
The OxyPrem team, headed by UZH Entrepreneur Fellow Alumnus Stefan Kleiser, are on a high. Only a few days ago their device OxyPrem 1.4 was granted the CE mark.
On Digital Day, UZH presents ways in which digital technology can change and advance medicine.
The Future.preneurship-program is an official spin-off of Impact Hub Zürich, the hot spot for innovation and startups in Switzerland with a community of over 1’500 entrepreneurs. Future.preneurship connects career starters with innovative companies for internships.
Zurich is the most innovative region in Europe according to the 9th Regionale Innovationsanzeiger (RIS) of the European Commission.
The top 30 finalists of the >>venture>> competition in the categories Hardware, Health & Nutrition, and Software & Services have been announced. Congratulations EraCal Therapeutics and Legartis for joining the finalists!
Switzerland is the European leader with its strong biotech start-up ecosystem. According to "nature biotechnology", Switzerland ranks first place in scientific output, patenting activity, and venture capital availability.
Hookipa Pharma, a University of Zurich (UZH) spin-off company, made its initial public offering (IPO) at Nasdaq in New York.
The paper focuses on the role of research-intensive universities in stimulating and supporting initiatives and programmes related to student entrepreneurship, but also on their role as drivers of entrepreneurial ecosystems.
Yannick Devaud, a Post-doctoral fellow at the University Hospital Zurich, is one of the four winners of Venture Kick Winners Nationwide.
UZH spin-off Anaveon successfully closed a CHF 35 million Series A financing with the lead investor Syncona Ltd. based in the a UK.
Let us introduce you to the Startup & Innovation World. Find unique internships and get a chance to get into untested waters. Get prepared for the Future of Work. Become a Future.preneur.
Learn more about the UZH Innovation Hub on the new UZH website regarding innovation, entrepreneurship and venture creation.
On Friday, Dec-7, the 2018 edition of the UZH Social Entrepreneurship seminar came to an end. This year, students were pitching social business ideas to either decrease plastic waste or to improve basic opportunities to children of migrant families.
